| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.9M | +38.7% |
| R&D Expense | $148.3M | -14.5% |
| SG&A Expense | $59.5M | +4.5% |
| Interest Expense | $4.1M | +22.4% |
| Income Tax | $0 | — |
| Net Income | -$171.7M | +15.9% |
| EPS (Basic) | -$1.48 | +32.1% |
| EPS (Diluted) | -$1.48 | +32.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $174.6M | +35.4% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $214.1M | -32.9% |
| Total Assets | $226.1M | -32.4% |
| Current Liabilities | $63.6M | -30.5% |
| Long-term Debt | $23.1M | -7.1% |
| Total Liabilities | $189.2M | -21.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$168.9M | -242.1% |
| Capital Expenditures | $2.2M | -1.3% |
| Investing Cash Flow | $119.9M | +178.5% |
| Financing Cash Flow | $94.7M | -38.1% |
| Free Cash Flow | -$171.1M | -231.7% |
| Stockholders' Equity |
| $36.9M |
| -59.9% |